Authors:
Flinn, IW
O'Donnell, PV
Goodrich, A
Vogelsang, G
Abrams, R
Noga, S
Marcellus, D
Borowitz, M
Jones, R
Ambinder, RF
Citation: Iw. Flinn et al., Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma, BIOL BLOOD, 6(6), 2000, pp. 628-632
Citation: J. Margolis et G. Vogelsang, An old drug for a new disease: Pentostatin (Nipent) in acute graft-versus-host disease, SEMIN ONCOL, 27(2), 2000, pp. 72-77
Authors:
van der Wall, E
Horn, T
Bright, E
Passos-Coehlo, JL
Bond, S
Clarke, B
Altomonte, V
McIntyre, K
Vogelsang, G
Noga, SJ
Davis, JM
Thomassen, J
Ohly, K
Lee, SM
Fetting, J
Armstrong, DK
Davidson, NE
Hess, AD
Kennedy, MJ
Citation: E. Van Der Wall et al., Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells, BR J CANC, 83(11), 2000, pp. 1405-1411
Authors:
Flinn, IW
Byrd, JC
Morrison, C
Jamison, J
Diehl, LF
Murphy, T
Piantadosi, S
Seifter, E
Ambinder, RF
Vogelsang, G
Grever, MR
Citation: Iw. Flinn et al., Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies, BLOOD, 96(1), 2000, pp. 71-75
Citation: B. Mookerjee et al., Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus, BONE MAR TR, 24(5), 1999, pp. 517-520